<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="correction">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">viruses</journal-id>
      <journal-title>Viruses</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Viruses</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Viruses</abbrev-journal-title>
      <issn pub-type="epub">1999-4915</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/v4102014</article-id>
      <article-id pub-id-type="publisher-id">viruses-04-02014</article-id>
      <article-categories>
        <subj-group>
          <subject>Correction</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Brockman, M.A., <italic>et al.</italic>, Human Leukocyte Antigen (HLA) Class I Down-Regulation by Human Immunodeficiency Virus Type 1 Negative Factor (HIV-1 Nef): What Might We Learn From Natural Sequence Variants? <italic>Viruses</italic> 2012, <italic>4</italic>, 1711-1730</article-title>
      </title-group>
	  <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Mwimanzi</surname>
            <given-names>Philip</given-names>
          </name>
          <xref rid="af1-viruses-04-02014" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Markle</surname>
            <given-names>Tristan J.</given-names>
          </name>
          <xref rid="af1-viruses-04-02014" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ueno</surname>
            <given-names>Takamasa</given-names>
          </name>
          <xref rid="af2-viruses-04-02014" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brockman</surname>
            <given-names>Mark A.</given-names>
          </name>
          <xref rid="af1-viruses-04-02014" ref-type="aff">1</xref>
          <xref rid="af3-viruses-04-02014" ref-type="aff">3</xref>
          <xref rid="c1-viruses-04-02014" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      
      <aff id="af1-viruses-04-02014"><label>1 </label>Department of Molecular Biology and Biochemistry, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada; Email: <email>philip_mwimanzi@sfu.ca</email> (P.M.); <email>tmarkle@sfu.ca</email> (T.J.M.)</aff>
      <aff id="af2-viruses-04-02014"><label>2 </label>Center for AIDS Research, Kumamoto University, 2-2-1 Honjo, Chuo-ku, Kumamoto 860-0811, Japan; Email: <email>uenotaka@kumamoto-u.ac.jp</email></aff>
      <aff id="af3-viruses-04-02014"><label>3 </label>Faculty of Health Sciences, Simon Fraser University, 8888 University Drive, Burnaby, British Columbia V5A 1S6, Canada</aff>
      <author-notes>
        <corresp id="c1-viruses-04-02014"><label>*</label> Author to whom correspondence should be addressed; Email: <email>mark_brockman@sfu.ca</email>; Tel.: +1-778-782-3341; Fax: +1-778-782-5583.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>10</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection">
	  <month>10</month>
        <year>2012</year>
      </pub-date>
      <volume>4</volume>
      <issue>10</issue>
      <fpage>2014</fpage>
      <lpage>2015</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>05</day>
          <month>10</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>05</day>
          <month>10</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©  2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<uri>http://creativecommons.org/licenses/by/3.0/</uri>).</p>
        </license>
      </permissions>
    </article-meta>
  </front>
  <body>
    <p>In the <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="4" page="1711" id="viruses-04-02014" xlink:href="http://www.mdpi.com/1999-4915/4/9/1711" ext-link-type="uri">original manuscript</related-article>, the text in figure 1 is illegible. Furthermore, there is an unnecessary carriage return (page 1716, ~line 18) "crystallographic ... methods".</p>
    <p>“…The N-terminal anchor domain of Nef is required for membrane association and localization into detergent-insoluble “lipid rafts” [77], while the central core encodes numerous protein interaction and intracellular trafficking motifs that contribute differentially to diverse Nef functions [78]. The central core domain of Nef adopts a stable tertiary fold, permitting its early characterization using both NMR and X-ray crystallographic methods [79,80]. Our understanding of Nef-mediated HLA down-regulation has been significantly enhanced by the recently reported crystal structure of Nef protein in complex with the MHC-I cytoplasmic domain and the μ1 subunit of the clatherin AP1 complex [76].”</p>
    <p>The correct figure should be:</p>
    <fig id="viruses-04-02014-f001" position="anchor">
      <label>Figure 1</label>
      <caption>
        <p>Presentation of viral peptide antigens by Human Leukocyte Antigen (HLA) class I. Human immunodeficiency virus type 1 (HIV-1) proviral gene expression, including RNA transcription (<bold>a</bold>) and protein translation (<bold>b</bold>); generates functional viral proteins (<bold>c</bold>) as well as truncated or mis-folded proteins that are degraded by the cellular proteasome complex to form short antigenic peptides (<bold>d</bold>); These peptides are transported from the cytoplasm into the endoplasmic reticulum (ER) (<bold>e</bold>) where they can be loaded onto HLA-I molecules.Peptide/HLA complexes traffic from the ER through the Golgi and secretory vesicle (SV) network to the plasma cell membrane, where the peptide antigens are presented to circulating cytotoxic T lymphocytes (CTL) (<bold>f</bold>); The viral Nef protein shuttles HLA molecules located at the cell surface or within the <italic>trans</italic>-Golgi network into lysosomal compartments (<bold>g</bold>); where they are degraded.In the absence of Nef-mediated HLA down-regulation, antigen-specific CTL respond to stimulation by releasing cytotoxic molecules, including perforin and granzymes, resulting in elimination of the virus-infected cell (h).</p>
      </caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="viruses-04-02014-g001.tif"/>
    </fig>
  </body>
  <back>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-viruses-04-02014">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mwimanzi</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Markle</surname>
              <given-names>T.J.</given-names>
            </name>
            <name>
              <surname>Ueno</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Brockman</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Human Leukocyte Antigen (HLA) Class I Down-Regulation by Human Immunodeficiency Virus Type 1 Negative Factor (HIV-1 Nef): What Might We Learn From Natural Sequence Variants?</article-title>
          <source>Viruses</source>
          <year>2012</year>
          <volume>4</volume>
          <fpage>1711</fpage>
          <lpage>1730</lpage>
          <pub-id pub-id-type="doi">10.3390/v4091711</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
